Global Soft-Contact Blood Lancet market size is predicted to grow from US$ 941 million in 2025 to US$ 1298 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.

Global Soft-Contact Blood Lancet Market Trends, Growth | CAGR Of 4.8%

The global Soft-Contact Blood Lancet market size is predicted to grow from US$ 941 million in 2025 to US$ 1298 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032. In 2025, the global annual production capacity of soft-contact blood lancets was approximately 19.5 billion units, while actual output reached around 16.03 billion units. The global average selling price was approximately US$0.060 per unit. Supported by large-scale automated manufacturing and stable demand from chronic disease management, major manufacturers maintained gross profit margins in the range of 30%?45%. Soft-contact blood lancets are disposable medical devices used for capillary blood sampling. They incorporate a soft-contact or pressure-activated mechanism that minimizes skin trauma and reduces pain during puncture while ensuring consistent penetration depth. These lancets are widely applied in blood glucose monitoring, point-of-care testing, and home healthcare scenarios. Upstream of the soft-contact blood lancet supply chain consists of medical-grade stainless steel needles, polymer resins, spring components, packaging materials, and sterilization consumables. Midstream manufacturers focus on precision injection molding, needle grinding, automated assembly, sterilization, and quality control, with major production centers located in China, the United States, Europe, and Southeast Asia. Downstream channels include hospitals, diagnostic laboratories, pharmacies, medical distributors, and home healthcare brands. End users place strong emphasis on safety, pain reduction, sterility assurance, consistency, and compatibility with various lancing devices. The soft-contact blood lancet market in 2025 is supported by the continued rise in diabetes prevalence and the expansion of home-based healthcare. Compared with traditional lancets, soft-contact designs provide better user comfort and improved sampling consistency, driving their gradual replacement of conventional products. Although unit prices remain relatively low, high shipment volumes and automated manufacturing enable suppliers to maintain stable margins. Regulatory compliance and sterilization standards remain key barriers to entry. Future growth will be driven by chronic disease management, aging populations, and increasing healthcare accessibility in emerging markets. Infinity Market Research newest research report, the ?Soft-Contact Blood Lancet Industry Forecast? looks at past sales and reviews total world Soft-Contact Blood Lancet sales in 2025, providing a comprehensive analysis by region and market sector of projected Soft-Contact Blood Lancet sales for 2026 through 2032. With Soft-Contact Blood Lancet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft-Contact Blood Lancet industry. This Insight Report provides a comprehensive analysis of the global Soft-Contact Blood Lancet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soft-Contact Blood Lancet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Soft-Contact Blood Lancet market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft-Contact Blood Lancet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft-Contact Blood Lancet. This report presents a comprehensive overview, market shares, and growth opportunities of Soft-Contact Blood Lancet market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Safety &nbsp;&nbsp;&nbsp; Routine &nbsp;&nbsp;&nbsp; Segmentation by Length: &nbsp;&nbsp;&nbsp; Standard Length &nbsp;&nbsp;&nbsp; Short-length &nbsp;&nbsp;&nbsp; Long-length Segmentation by Application: &nbsp;&nbsp;&nbsp; Newborn Screening &nbsp;&nbsp;&nbsp; Blood Glucose Test &nbsp;&nbsp;&nbsp; Rapid Complete Blood Count &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; Lifescan &nbsp;&nbsp;&nbsp; BD &nbsp;&nbsp;&nbsp; MTD Group &nbsp;&nbsp;&nbsp; Greiner Bio One &nbsp;&nbsp;&nbsp; Owen Mumford &nbsp;&nbsp;&nbsp; Cardinal Health &nbsp;&nbsp;&nbsp; Ascensia &nbsp;&nbsp;&nbsp; Abbott &nbsp;&nbsp;&nbsp; B. Braun &nbsp;&nbsp;&nbsp; Terumo &nbsp;&nbsp;&nbsp; I-SENS &nbsp;&nbsp;&nbsp; Nipro &nbsp;&nbsp;&nbsp; ICU Medical &nbsp;&nbsp;&nbsp; Sarstedt &nbsp;&nbsp;&nbsp; Sannuo Biosensor &nbsp;&nbsp;&nbsp; Yuwell Medical &nbsp;&nbsp;&nbsp; Tianjin Huahong &nbsp;&nbsp;&nbsp; Suzhou Slink Medical &nbsp;&nbsp;&nbsp; Shandong Lianfa &nbsp;&nbsp;&nbsp; Puan Medical Key Questions Addressed in this Report What is the 10-year outlook for the global Soft-Contact Blood Lancet market? What factors are driving Soft-Contact Blood Lancet market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Soft-Contact Blood Lancet market opportunities vary by end market size? How does Soft-Contact Blood Lancet break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Soft-Contact Blood Lancet Annual Sales 2021-2032 &nbsp;2.1.2 World Current & Future Analysis for Soft-Contact Blood Lancet by Geographic Region, 2021, 2025 & 2032 &nbsp;2.1.3 World Current & Future Analysis for Soft-Contact Blood Lancet by Country/Region, 2021, 2025 & 2032 &nbsp;2.2 Soft-Contact Blood Lancet Segment by Type &nbsp;2.2.1 Safety &nbsp;2.2.2 Routine &nbsp;2.2.3 Soft-Contact Blood Lancet Sales by Type &nbsp;2.2.3.1 Global Soft-Contact Blood Lancet Sales Market Share by Type (2021-2026) &nbsp;2.2.3.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Type (2021-2026) &nbsp;2.2.3.3 Global Soft-Contact Blood Lancet Sale Price by Type (2021-2026) &nbsp;2.3 Soft-Contact Blood Lancet Segment by Length &nbsp;2.3.1 Standard Length &nbsp;2.3.2 Short-length &nbsp;2.3.3 Long-length &nbsp;2.3.4 Soft-Contact Blood Lancet Sales by Length &nbsp;2.3.4.1 Global Soft-Contact Blood Lancet Sales Market Share by Length (2021-2026) &nbsp;2.3.4.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Length (2021-2026) &nbsp;2.3.4.3 Global Soft-Contact Blood Lancet Sale Price by Length (2021-2026) &nbsp;2.4 Soft-Contact Blood Lancet Segment by Application &nbsp;2.4.1 Newborn Screening &nbsp;2.4.2 Blood Glucose Test &nbsp;2.4.3 Rapid Complete Blood Count &nbsp;2.4.4 Others &nbsp;2.4.5 Soft-Contact Blood Lancet Sales by Application &nbsp;2.4.5.1 Global Soft-Contact Blood Lancet Sale Market Share by Application (2021-2026) &nbsp;2.4.5.2 Global Soft-Contact Blood Lancet Revenue and Market Share by Application (2021-2026) &nbsp;2.4.5.3 Global Soft-Contact Blood Lancet Sale Price by Application (2021-2026) 3 Global by Company &nbsp;3.1 Global Soft-Contact Blood Lancet Breakdown Data by Company &nbsp;3.1.1 Global Soft-Contact Blood Lancet Annual Sales by Company (2021-2026) &nbsp;3.1.2 Global Soft-Contact Blood Lancet Sales Market Share by Company (2021-2026) &nbsp;3.2 Global Soft-Contact Blood Lancet Annual Revenue by Company (2021-2026) &nbsp;3.2.1 Global Soft-Contact Blood Lancet Revenue by Company (2021-2026) &nbsp;3.2.2 Global Soft-Contact Blood Lancet Revenue Market Share by Company (2021-2026) &nbsp;3.3 Global Soft-Contact Blood Lancet Sale Price by Company &nbsp;3.4 Key Manufacturers Soft-Contact Blood Lancet Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Soft-Contact Blood Lancet Product Location Distribution &nbsp;3.4.2 Players Soft-Contact Blood Lancet Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Soft-Contact Blood Lancet by Geographic Region &nbsp;4.1 World Historic Soft-Contact Blood Lancet Market Size by Geographic Region (2021-2026) &nbsp;4.1.1 Global Soft-Contact Blood Lancet Annual Sales by Geographic Region (2021-2026) &nbsp;4.1.2 Global Soft-Contact Blood Lancet Annual Revenue by Geographic Region (2021-2026) &nbsp;4.2 World Historic Soft-Contact Blood Lancet Market Size by Country/Region (2021-2026) &nbsp;4.2.1 Global Soft-Contact Blood Lancet Annual Sales by Country/Region (2021-2026) &nbsp;4.2.2 Global Soft-Contact Blood Lancet Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas Soft-Contact Blood Lancet Sales Growth &nbsp;4.4 APAC Soft-Contact Blood Lancet Sales Growth &nbsp;4.5 Europe Soft-Contact Blood Lancet Sales Growth &nbsp;4.6 Middle East & Africa Soft-Contact Blood Lancet Sales Growth 5 Americas &nbsp;5.1 Americas Soft-Contact Blood Lancet Sales by Country &nbsp;5.1.1 Americas Soft-Contact Blood Lancet Sales by Country (2021-2026) &nbsp;5.1.2 Americas Soft-Contact Blood Lancet Revenue by Country (2021-2026) &nbsp;5.2 Americas Soft-Contact Blood Lancet Sales by Type (2021-2026) &nbsp;5.3 Americas Soft-Contact Blood Lancet Sales by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Soft-Contact Blood Lancet Sales by Region &nbsp;6.1.1 APAC Soft-Contact Blood Lancet Sales by Region (2021-2026) &nbsp;6.1.2 APAC Soft-Contact Blood Lancet Revenue by Region (2021-2026) &nbsp;6.2 APAC Soft-Contact Blood Lancet Sales by Type (2021-2026) &nbsp;6.3 APAC Soft-Contact Blood Lancet Sales by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Soft-Contact Blood Lancet by Country &nbsp;7.1.1 Europe Soft-Contact Blood Lancet Sales by Country (2021-2026) &nbsp;7.1.2 Europe Soft-Contact Blood Lancet Revenue by Country (2021-2026) &nbsp;7.2 Europe Soft-Contact Blood Lancet Sales by Type (2021-2026) &nbsp;7.3 Europe Soft-Contact Blood Lancet Sales by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Soft-Contact Blood Lancet by Country &nbsp;8.1.1 Middle East & Africa Soft-Contact Blood Lancet Sales by Country (2021-2026) &nbsp;8.1.2 Middle East & Africa Soft-Contact Blood Lancet Revenue by Country (2021-2026) &nbsp;8.2 Middle East & Africa Soft-Contact Blood Lancet Sales by Type (2021-2026) &nbsp;8.3 Middle East & Africa Soft-Contact Blood Lancet Sales by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Soft-Contact Blood Lancet &nbsp;10.3 Manufacturing Process Analysis of Soft-Contact Blood Lancet &nbsp;10.4 Industry Chain Structure of Soft-Contact Blood Lancet 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Soft-Contact Blood Lancet Distributors &nbsp;11.3 Soft-Contact Blood Lancet Customer 12 World Forecast Review for Soft-Contact Blood Lancet by Geographic Region &nbsp;12.1 Global Soft-Contact Blood Lancet Market Size Forecast by Region &nbsp;12.1.1 Global Soft-Contact Blood Lancet Forecast by Region (2027-2032) &nbsp;12.1.2 Global Soft-Contact Blood Lancet Annual Revenue Forecast by Region (2027-2032) &nbsp;12.2 Americas Forecast by Country (2027-2032) &nbsp;12.3 APAC Forecast by Region (2027-2032) &nbsp;12.4 Europe Forecast by Country (2027-2032) &nbsp;12.5 Middle East & Africa Forecast by Country (2027-2032) &nbsp;12.6 Global Soft-Contact Blood Lancet Forecast by Type (2027-2032) &nbsp;12.7 Global Soft-Contact Blood Lancet Forecast by Application (2027-2032) 13 Key Players Analysis &nbsp;13.1 Roche &nbsp;13.1.1 Roche Company Information &nbsp;13.1.2 Roche Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.1.3 Roche Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.1.4 Roche Main Business Overview &nbsp;13.1.5 Roche Latest Developments &nbsp;13.2 Lifescan &nbsp;13.2.1 Lifescan Company Information &nbsp;13.2.2 Lifescan Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.2.3 Lifescan Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.2.4 Lifescan Main Business Overview &nbsp;13.2.5 Lifescan Latest Developments &nbsp;13.3 BD &nbsp;13.3.1 BD Company Information &nbsp;13.3.2 BD Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.3.3 BD Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.3.4 BD Main Business Overview &nbsp;13.3.5 BD Latest Developments &nbsp;13.4 MTD Group &nbsp;13.4.1 MTD Group Company Information &nbsp;13.4.2 MTD Group Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.4.3 MTD Group Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.4.4 MTD Group Main Business Overview &nbsp;13.4.5 MTD Group Latest Developments &nbsp;13.5 Greiner Bio One &nbsp;13.5.1 Greiner Bio One Company Information &nbsp;13.5.2 Greiner Bio One Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.5.3 Greiner Bio One Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.5.4 Greiner Bio One Main Business Overview &nbsp;13.5.5 Greiner Bio One Latest Developments &nbsp;13.6 Owen Mumford &nbsp;13.6.1 Owen Mumford Company Information &nbsp;13.6.2 Owen Mumford Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.6.3 Owen Mumford Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.6.4 Owen Mumford Main Business Overview &nbsp;13.6.5 Owen Mumford Latest Developments &nbsp;13.7 Cardinal Health &nbsp;13.7.1 Cardinal Health Company Information &nbsp;13.7.2 Cardinal Health Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.7.3 Cardinal Health Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.7.4 Cardinal Health Main Business Overview &nbsp;13.7.5 Cardinal Health Latest Developments &nbsp;13.8 Ascensia &nbsp;13.8.1 Ascensia Company Information &nbsp;13.8.2 Ascensia Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.8.3 Ascensia Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.8.4 Ascensia Main Business Overview &nbsp;13.8.5 Ascensia Latest Developments &nbsp;13.9 Abbott &nbsp;13.9.1 Abbott Company Information &nbsp;13.9.2 Abbott Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.9.3 Abbott Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.9.4 Abbott Main Business Overview &nbsp;13.9.5 Abbott Latest Developments &nbsp;13.10 B. Braun &nbsp;13.10.1 B. Braun Company Information &nbsp;13.10.2 B. Braun Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.10.3 B. Braun Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.10.4 B. Braun Main Business Overview &nbsp;13.10.5 B. Braun Latest Developments &nbsp;13.11 Terumo &nbsp;13.11.1 Terumo Company Information &nbsp;13.11.2 Terumo Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.11.3 Terumo Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.11.4 Terumo Main Business Overview &nbsp;13.11.5 Terumo Latest Developments &nbsp;13.12 I-SENS &nbsp;13.12.1 I-SENS Company Information &nbsp;13.12.2 I-SENS Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.12.3 I-SENS Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.12.4 I-SENS Main Business Overview &nbsp;13.12.5 I-SENS Latest Developments &nbsp;13.13 Nipro &nbsp;13.13.1 Nipro Company Information &nbsp;13.13.2 Nipro Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.13.3 Nipro Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.13.4 Nipro Main Business Overview &nbsp;13.13.5 Nipro Latest Developments &nbsp;13.14 ICU Medical &nbsp;13.14.1 ICU Medical Company Information &nbsp;13.14.2 ICU Medical Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.14.3 ICU Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.14.4 ICU Medical Main Business Overview &nbsp;13.14.5 ICU Medical Latest Developments &nbsp;13.15 Sarstedt &nbsp;13.15.1 Sarstedt Company Information &nbsp;13.15.2 Sarstedt Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.15.3 Sarstedt Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.15.4 Sarstedt Main Business Overview &nbsp;13.15.5 Sarstedt Latest Developments &nbsp;13.16 Sannuo Biosensor &nbsp;13.16.1 Sannuo Biosensor Company Information &nbsp;13.16.2 Sannuo Biosensor Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.16.3 Sannuo Biosensor Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.16.4 Sannuo Biosensor Main Business Overview &nbsp;13.16.5 Sannuo Biosensor Latest Developments &nbsp;13.17 Yuwell Medical &nbsp;13.17.1 Yuwell Medical Company Information &nbsp;13.17.2 Yuwell Medical Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.17.3 Yuwell Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.17.4 Yuwell Medical Main Business Overview &nbsp;13.17.5 Yuwell Medical Latest Developments &nbsp;13.18 Tianjin Huahong &nbsp;13.18.1 Tianjin Huahong Company Information &nbsp;13.18.2 Tianjin Huahong Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.18.3 Tianjin Huahong Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.18.4 Tianjin Huahong Main Business Overview &nbsp;13.18.5 Tianjin Huahong Latest Developments &nbsp;13.19 Suzhou Slink Medical &nbsp;13.19.1 Suzhou Slink Medical Company Information &nbsp;13.19.2 Suzhou Slink Medical Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.19.3 Suzhou Slink Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.19.4 Suzhou Slink Medical Main Business Overview &nbsp;13.19.5 Suzhou Slink Medical Latest Developments &nbsp;13.20 Shandong Lianfa &nbsp;13.20.1 Shandong Lianfa Company Information &nbsp;13.20.2 Shandong Lianfa Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.20.3 Shandong Lianfa Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.20.4 Shandong Lianfa Main Business Overview &nbsp;13.20.5 Shandong Lianfa Latest Developments &nbsp;13.21 Puan Medical &nbsp;13.21.1 Puan Medical Company Information &nbsp;13.21.2 Puan Medical Soft-Contact Blood Lancet Product Portfolios and Specifications &nbsp;13.21.3 Puan Medical Soft-Contact Blood Lancet Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.21.4 Puan Medical Main Business Overview &nbsp;13.21.5 Puan Medical Latest Developments 14 Research Findings and Conclusion

Report	Global Soft-Contact Blood Lancet Market Size, Share and Analysis Report 2026-2032
Selected License	Multi ID: ILR4599

Buyer Information

Order Summary